Affectis Pharmaceuticals AG
Records under this name other than the patents Affectis Pharmaceuticals AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 4 of 4 · Back to Affectis Pharmaceuticals AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,153,127 | Method of treating depression Formerly held Lapsed on the fee record Ended Apr 10, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2020 | From the USPTO record |
| US 8,268,861 | P2X7R antagonists and their use Lapsed on the fee record Ended Sep 18, 2016 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2016 | From the USPTO record |
| US 7,919,503 | P2X7R antagonists and their use Lapsed on the fee record Ended Apr 5, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2015 | From the USPTO record |
| US 7,767,398 | Means and methods for diagnosing and treating affective disorders Lapsed on the fee record Ended Aug 3, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2014 | From the USPTO record |